Abstract: Disclosed are methods of introducing a suspension or solution of a medicament, preferably mometasone furoate anhydrous, into a metered dose inhaler container.

Abstract: A liquid suspension comprising an antifungally effective amount of the micronized compound represented by the chemical structural formula I: at least one thickening agent, a non-ionic surfactant, and a pharmaceutically acceptable liquid carrier is disclosed.

Abstract: A liquid suspension comprising an antifungally effective amount of the micronized compound represented by the chemical structural formula I: at least one thickening agent, a non-ionic surfactant, and a pharmaceutically acceptable liquid carrier is disclosed.

Abstract: Disclosed are aerosolized formulations for the treatment of asthma that contain mometasone furoate and formoterol fumarate and processes for preparing the same.

Abstract: Disclosed are aerosolized formulations for the treatment of asthma that contain mometasone furoate and processes for preparing the same.

Abstract: Disclosed are methods of introducing a suspension or solution of a medicament, preferably mometasone furoate anhydrous, into a metered dose inhaler container, said container having a valve attached thereto, said method comprising the steps of introducing mometasone furoate anhydrous, a surfactant and a chlorofluorocarbon free propellant into a vessel that is held under pressure to form a suspension or solution, circulating said suspension or solution from the vessel through a line which includes a filling head, bringing said filling head into communication with said metered dose inhaler container through said valve of said metered dose inhaler container, introducing a quantity of such suspension or solution into the container from the filling head of the line through said valve of said metered dose inhaler container, withdrawing said filling head from said metered dose inhaler container, and sealing said metered dose inhaler container, as well as the products produced thereby having an improved particle size

Abstract: Disclosed are methods for determining the smoothness index of the interior of a metered dose container.

Abstract: Disclosed are aerosolized formulations for the treatment of asthma that contain mometasone furoate and formoterol fumarate and processes for preparing the same.

Abstract: Disclosed are aerosolized formulations for the treatment of asthma that contain mometasone furoate and processes for preparing the same.

Abstract: Disclosed is a method of determining the formation of a secondary structure of a thixotropic formulation, said method comprising a) placing an amount of said thixotropic formulation on a transparent object; b) capturing an image of said thixotropic formulation by back-scattered light by using a particle vision and measurement probe; c) converting said image to a video image; d) analyzing said video image to determine the amount of time it takes for the formation of said secondary structure within said thixotropic formulation, and novel formulations concerning the same.

Abstract: Disclosed are methods for determining the smoothness index of the interior of a metered dose container.

Abstract: Disclosed are methods of introducing a suspension or solution of a medicament, preferably mometasone furoate anhydrous, into a metered dose inhaler container, said container having a valve attached thereto, said method comprising the steps of introducing mometasone furoate anhydrous, a surfactant and a chlorflourocarbon free propellant into a vessel that is held under pressure to form a suspension or solution, circulating said suspension or solution from the vessel through a line which includes a filling head, bringing said filling head into communication with said metered dose inhaler container through said valve of said metered dose inhaler container, introducing a quantity of such suspension or solution into the container from the filling head of the line through said valve of said metered dose inhaler container, withdrawing said filling head from said metered dose inhaler container, and sealing said metered dose inhaler container, as well as the products produced thereby having an improved particle size d

Abstract: Disclosed are aerosolized formulations for the treatment of asthma that contain mometasone furoate and formoterol fumarate and processes for preparing the same.

Abstract: A liquid suspension comprising an antifungally effective amount of the micronized compound represented by the chemical structural formula I: 1